SNS Financial Group’s iShares Biotechnology ETF IBB Stock Holding History

SNS Financial Group’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$341K	Buy	+1,795	New	+$309K	0.01%	438
2017 Q4	–	Sell	-12,288	Closed	-$1.37M	–	178
2017 Q3	$1.37M	Buy	+12,288	New	+$1.31M	0.35%	59
2015 Q4	–	Sell	-12,561	Closed	-$1.27M	–	127
2015 Q3	$1.27M	Buy	+12,561	New	+$1.51M	0.35%	53
2014 Q3	–	Sell	-23,289	Closed	-$2M	–	118
2014 Q2	$2M	Buy	+23,289	New	+$1.83M	0.8%	25

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.9% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

SNS Financial Group's IBB Position: Q2 2026 in Review

SNS Financial Group opened a new position in iShares Biotechnology ETF (IBB) in Q2 2026: 1,795 shares worth $341K. The stake represents 0.01% of the portfolio and ranks #438 among its holdings. This is a return to the name: SNS Financial Group previously reported a position in IBB as recently as Q3 2017.

SNS Financial Group first reported a position in IBB in Q2 2014 and has held it in 4 quarters since. The position peaked at $2M in Q2 2014. 960 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

SNS Financial Group held 1,795 shares of iShares Biotechnology ETF worth $341K as of Q2 2026.
iShares Biotechnology ETF was a new SNS Financial Group position in Q2 2026.
iShares Biotechnology ETF made up 0.01% of SNS Financial Group's portfolio in Q2 2026, its #438 holding.
SNS Financial Group first reported a position in iShares Biotechnology ETF in Q2 2014 and has held it in 4 quarters since.
SNS Financial Group's iShares Biotechnology ETF position peaked at $2M in Q2 2014.
960 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on SNS Financial Group's 13F filing for Q2 2026, filed 11 Aug 2026.